petersuber<p>Update. New study: "<a href="https://fediscience.org/tags/NIH" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>NIH</span></a> investment in drugs approved from 2010 to 2019 was not less than investment by the <a href="https://fediscience.org/tags/pharmaceutical" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>pharmaceutical</span></a> industry, with comparable accounting for basic and applied research, failed clinical trials, and cost of capital or discount rates."<br><a href="https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378" rel="nofollow noopener" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">jamanetwork.com/journals/jama-</span><span class="invisible">health-forum/fullarticle/2804378</span></a> </p><p>PS: Relevant to (1) <a href="https://fediscience.org/tags/Trump" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Trump</span></a> admin cutbacks to NIH <a href="https://fediscience.org/tags/funding" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>funding</span></a> and (2) industry <a href="https://fediscience.org/tags/patents" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>patents</span></a> and licensing terms on approved drugs. </p><p><a href="https://fediscience.org/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Medicine</span></a> <a href="https://fediscience.org/tags/Pharma" class="mention hashtag" rel="nofollow noopener" target="_blank">#<span>Pharma</span></a></p>